Latest news
Silexion Therapeutics (SLXN US): Synthetic Expert Call Transcript (10 Aug 2026) - SmartkarmaSmartkarma · Mon, 10 Aug 2026 07:21:48 GMTTop Silexion Therapeutics Corp - Warrant (SLXNW) Competitors 2026 - MarketBeatMarketBeat · Sun, 09 Aug 2026 13:51:42 GMTSilexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers - BitgetBitget · Sun, 09 Aug 2026 13:24:56 GMTSilexion Therapeutics (NASDAQ: SLXN) files S-1 for best-efforts unit sale - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 22:52:53 GMTSilexion to present preclinical data on SIL-204 at GI cancer event - Investing.comInvesting.com · Tue, 04 Aug 2026 15:03:49 GMTSilexion Therapeutics Reports New Positive Preclinical - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 13:15:00 GMTSilexion's SIL204 Alters Three Immune Pathways in Cancer Cells - stocktitan.netstocktitan.net · Tue, 04 Aug 2026 13:15:00 GMTSilexion Therapeutics restores Nasdaq audit committee compliance with new appointment - TradingViewTradingView · Mon, 03 Aug 2026 13:33:01 GMT